Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Synergism Between PDE4 and PI3Kδ Inhibitors in DLBCL: Improved Clinical Activity with the Potential for Lower Toxicity

Jeffrey Cooney, Long Wang, MD, An-Ping Lin, MD, Daifeng Jiang, PhD, Avvaru Suhasini, PhD, Ricardo C Aguiar, MD PhD

Blood (2016) 128 (22): 2938.

https://doi.org/10.1182/blood.V128.22.2938.2938

Published: 2016

Journal Articles

MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module

Daifeng Jiang, Ricardo C. T. Aguiar

Blood (2014) 123 (1): 86–93.

https://doi.org/10.1182/blood-2013-07-515254

Published: 2014

Includes: Supplemental data

Journal Articles

Heightened DNA Damage Response and p53 Activation In MiR-155 Null Cells Are Context Specific and Aid Dependent

Hakim Bouamar, PhD, Long Wang, MD, Manoela Ortega, PhD, An-Ping Lin, MD, Daifeng Jiang, PhD, Ricardo Aguiar, MD, PhD

Blood (2013) 122 (21): 2279.

https://doi.org/10.1182/blood.V122.21.2279.2279

Published: 2013

Journal Articles

Microrna-155 Controls The RB/E2F Axis In Normal and Malignant B Cells Via The Non-Canonical TGFβ1-SMAD5 Signaling Module

Daifeng Jiang, PhD, Ricardo Aguiar, MD, PhD

Blood (2013) 122 (21): 241.

https://doi.org/10.1182/blood.V122.21.241.241

Published: 2013

Journal Articles

A capture-sequencing strategy identifies IRF8 , EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma

Hakim Bouamar, Saman Abbas, An-Ping Lin, Long Wang, Daifeng Jiang, Kenneth N. Holder, Marsha C. Kinney, Scott Hunicke-Smith, Ricardo C. T. Aguiar

Blood (2013) 122 (5): 726–733.

https://doi.org/10.1182/blood-2013-04-495804

Published: 2013

Includes: Supplemental data

Journal Articles

Targeting of TNFAIP3 (A20) Links MiR-125a and MiR-125b to Constitutive Activation of the NF-KB Pathway and Lymphomagenesis

Sang-Woo Kim, PhD, Kumaraguruparan Ramasamy, PhD, Hakim Bouamar, PhD, Daifeng Jiang, PhD, Ricardo Aguiar, MD, PhD

Blood (2011) 118 (21): 774.

https://doi.org/10.1182/blood.V118.21.774.774

Published: 2011

NARROW

Synergism Between PDE4 and PI3Kδ Inhibitors in DLBCL: Improved Clinical Activity with the Potential for Lower Toxicity

MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module

Heightened DNA Damage Response and p53 Activation In MiR-155 Null Cells Are Context Specific and Aid Dependent

Microrna-155 Controls The RB/E2F Axis In Normal and Malignant B Cells Via The Non-Canonical TGFβ1-SMAD5 Signaling Module

A capture-sequencing strategy identifies IRF8 , EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma

Targeting of TNFAIP3 (A20) Links MiR-125a and MiR-125b to Constitutive Activation of the NF-KB Pathway and Lymphomagenesis

Email alerts

ASH Publications

American Society of Hematology

Synergism Between PDE4 and PI3Kδ Inhibitors in DLBCL: Improved Clinical Activity with the Potential for Lower Toxicity

MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module

Heightened DNA Damage Response and p53 Activation In MiR-155 Null Cells Are Context Specific and Aid Dependent

Microrna-155 Controls The RB/E2F Axis In Normal and Malignant B Cells Via The Non-Canonical TGFβ1-SMAD5 Signaling Module

A capture-sequencing strategy identifies IRF8 , EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma

Targeting of TNFAIP3 (A20) Links MiR-125a and MiR-125b to Constitutive Activation of the NF-KB Pathway and Lymphomagenesis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only